Trial Profile
Investigator initiated phase 2 trial of zoptarelin doxorubicin in prostate cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Zoptarelin doxorubicin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Dec 2015 New trial record